Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Jamie Findlow, Ray Borrow, David S. Stephens, Paul Liberator, Annaliesa S. Anderson, Paul Balmer & Luis Jodar. (2022) Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage. Expert Review of Vaccines 21:6, pages 753-769.
Read now
Read now
Jamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha, Cynthia Burman & Paul Balmer. (2022) Correlates of protection for meningococcal surface protein vaccines: lessons from the past. Expert Review of Vaccines 21:6, pages 739-751.
Read now
Read now
Marco Aurelio P. Safadi, Federico Martinón-Torres, Lidia Serra, Cynthia Burman & Jessica Presa. (2021) Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Review of Vaccines 20:4, pages 401-414.
Read now
Read now
Justine Alderfer, Raul E. Isturiz & Amit Srivastava. (2020) Lessons from mass vaccination response to meningococcal B outbreaks at US universities. Postgraduate Medicine 132:7, pages 614-623.
Read now
Read now
Paul Balmer, Johannes Beeslaar, Jamie Findlow & Amit Srivastava. (2020) Understanding immunogenicity assessments for meningococcal serogroup B vaccines. Postgraduate Medicine 132:2, pages 184-191.
Read now
Read now
Angee McDaniel, Amanda Dempsey & Amit Srivastava. (2019) A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine. Human Vaccines & Immunotherapeutics 15:11, pages 2729-2737.
Read now
Read now
Jamie Findlow, Paul Balmer & Ray Borrow. (2019) A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. Human Vaccines & Immunotherapeutics 15:10, pages 2491-2500.
Read now
Read now
Jamie Findlow, Charles Nuttens & Paula Kriz. (2019) Introduction of a second MenB vaccine into Europe – needs and opportunities for public health. Expert Review of Vaccines 18:3, pages 225-239.
Read now
Read now
Chen Stein-Zamir, Hanna Shoob, Nitza Abramson, Colin Block, Natan Keller, Joseph Jaffe & Lea Valinsky. (2019) Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Human Vaccines & Immunotherapeutics 15:1, pages 242-248.
Read now
Read now
Rodolfo Villena, Marco Aurelio P. Safadi, María Teresa Valenzuela, Juan P. Torres, Adam Finn & Miguel O'Ryan. (2018) Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines. Human Vaccines & Immunotherapeutics 14:5, pages 1042-1057.
Read now
Read now
Rolando Felipe Ochoa-Azze. (2018) Cross-protection induced by VA-MENGOC-BC® vaccine. Human Vaccines & Immunotherapeutics 14:5, pages 1064-1068.
Read now
Read now
Articles from other publishers (29)
Viktoriia Yu. Savitskaya, Nina G. Dolinnaya, Vadim V. Strekalovskikh, Elizaveta S. Peskovatskova, Viktoriia G. Snyga, Vadim S. Trefilov, Mayya V. Monakhova & Elena A. Kubareva. (2023) Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis. Medical Sciences 11:4, pages 76.
Crossref
Crossref
C. M. C. Rodrigues, L. MacDonald, R. Ure, A. Smith, J. C. Cameron & M. C. J. Maiden. (2023) Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022. mBio 14:2.
Crossref
Crossref
Daniele Veggi, Enrico Malito, Paola Lo Surdo, Werner Pansegrau, Valentina Rippa, Newton Wahome, Silvana Savino, Vega Masignani, Mariagrazia Pizza & Matthew J. Bottomley. (2022) Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096. Computational and Structural Biotechnology Journal 20, pages 2070-2081.
Crossref
Crossref
Yara Ruiz García, Woo-Yun Sohn, Kate L. Seib, Muhamed-Kheir Taha, Julio A. Vázquez, Ana Paula S. de Lemos, Kumaran Vadivelu, Mariagrazia Pizza, Rino Rappuoli & Rafik Bekkat-Berkani. (2021) Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. npj Vaccines 6:1.
Crossref
Crossref
Kelsey A. Pilewski, Kevin J. Kramer & Ivelin S. Georgiev. (2021) Simultaneous Immunization with Multiple Diverse Immunogens Alters Development of Antigen-Specific Antibody-Mediated Immunity. Vaccines 9:9, pages 964.
Crossref
Crossref
Henju Marjuki, How-Yi Chang, Nadav Topaz, Melissa J. Whaley, Jeni Vuong, Alexander Chen, Laurel T. Jenkins, Fang Hu, Susanna Schmink, Adam C. Retchless, Jennifer D. Thomas, Anna M. Acosta, Lucy A. McNamara, Heidi M. Soeters, Sarah Mbaeyi & Xin Wang. (2021) Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015–2016. mBio 12:3.
Crossref
Crossref
Snezana Delic, Vera Mijac, Ina Gajic, Dusan Kekic, Lazar Ranin, Boris Jegorovic, Davor Culic, Valentina Cirkovic, Marina Siljic, Maja Stanojevic, Metka Paragi, Milos Markovic & Natasa Opavski. (2021) A Laboratory-Based Surveillance Study of Invasive Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae Diseases in a Serbian Pediatric Population—Implications for Vaccination. Diagnostics 11:6, pages 1059.
Crossref
Crossref
Raquel Abad, Cristina García-Amil, Carmen Navarro, Elena Martín, Ariadna Martín-Díaz & Julio A Vázquez. (2021) Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015–2018: Evolution of the vaccine antigen factor H binding protein (FHbp). Journal of Infection 82:4, pages 37-44.
Crossref
Crossref
Sara R. Moore, Smrithi S. Menon, Claudio Cortes & Viviana P. Ferreira. (2021) Hijacking Factor H for Complement Immune Evasion. Frontiers in Immunology 12.
Crossref
Crossref
Priyal Bagwe, Lotika Bajaj, Rikhav Gala, Susu M. Zughaier, Mohammad N. Uddin & Martin J. D’Souza. (2020) Meningococcal Vaccines: Challenges and Prospects. Vaccines 8:4, pages 738.
Crossref
Crossref
Paul Liberator, Robert G. K. Donald, Paul Balmer, Jamie Findlow & Annaliesa S. Anderson. (2020) Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates. Frontiers in Microbiology 11.
Crossref
Crossref
Jamie Findlow, Christopher D. Bayliss, Peter T. Beernink, Ray Borrow, Paul Liberator & Paul Balmer. (2020) Broad vaccine protection against Neisseria meningitidis using factor H binding protein. Vaccine 38:49, pages 7716-7727.
Crossref
Crossref
Johannes Beeslaar, Judith Absalon, Annaliesa S. Anderson, Joseph J. Eiden, Paul Balmer, Shannon L. Harris, Thomas R. Jones, Robert E. O’Neill, Jean-Louis Pregaldien, David Radley, Roger Maansson, John Ginis, Amit Srivastava & John L. Perez. (2020) MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infectious Diseases and Therapy 9:3, pages 641-656.
Crossref
Crossref
Silvia Principato, Mariagrazia Pizza & Rino Rappuoli. (2020) Meningococcal factor H binding protein as immune evasion factor and vaccine antigen. FEBS Letters 594:16, pages 2657-2669.
Crossref
Crossref
Shannon L. Harris, Cuiwen Tan, John Perez, David Radley, Kathrin U. Jansen, Annaliesa S. Anderson & Thomas R. Jones. (2020) Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine. npj Vaccines 5:1.
Crossref
Crossref
Ronni A. G. da Silva, Andrey V. Karlyshev, Neil J. Oldfield, Karl G. Wooldridge, Christopher D. Bayliss, Ali Ryan & Ruth Griffin. (2019) Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates. Frontiers in Microbiology 10.
Crossref
Crossref
Abdul Razak Muttalif, Jessica V. Presa, Hammam Haridy, Amgad Gamil, Lidia C. Serra & Alejandro Cané. (2019) Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events. Infectious Diseases and Therapy 8:4, pages 569-579.
Crossref
Crossref
How-Yi Chang, Jeni Vuong, Fang Hu, Paul Liberator, Alex Chen, Cecilia B. Kretz, Amy Blain, Li Hao, Adam C. Retchless, Melissa J. Whaley, Annaliesa S. Anderson & Xin Wang. (2019) Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009–2014, prior to NmB vaccine licensure. Journal of Infection 79:5, pages 426-434.
Crossref
Crossref
José Francisco Santos-Neto, Viviane Matos Ferreira, Caroline Alves Feitosa, Martha Silvia Martinez-Silveira & Leila Carvalho Campos. (2019) Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. The Brazilian Journal of Infectious Diseases 23:4, pages 254-267.
Crossref
Crossref
Martin Christopher James Maiden. (2019) The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment. Frontiers in Immunology 9.
Crossref
Crossref
Lee H. Harrison. 2019. Vaccinations. Vaccinations
105
129
.
Jian Ma, Yunpeng Wang, Nuo Xu, Libo Jin, Jia Liu, Shaochen Xing & Xiaokun Li. (2018) Potential large scale production of meningococcal vaccines by stable overexpression of fHbp in the rice seeds. Protein Expression and Purification 152, pages 1-6.
Crossref
Crossref
Jo Anne Welsch, Shelly Senders, Brandon Essink, Thomas Klein, Igor Smolenov, Paola Pedotti, Silvia Barbi, Bikash Verma & Daniela Toneatto. (2018) Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study. Vaccine 36:35, pages 5309-5317.
Crossref
Crossref
Johannes Beeslaar, Judith Absalon, Paul Balmer, Amit Srivastava, Roger Maansson, Laura J. York & John L. Perez. (2018) Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults. Vaccine 36:28, pages 4004-4013.
Crossref
Crossref
Lisa K. McNeil, Robert G. K. Donald, Alexey Gribenko, Roger French, Nathaniel Lambert, Shannon L. Harris, Thomas R. Jones, Sheng Li, Gary Zlotnick, Ulrich Vogel, Heike Claus, Raquel Abad, Julio A. Vazquez, Ray Borrow, Jamie Findlow, Muhamed-Kheir Taha, Ala-Eddine Deghmane, Dominique A. Caugant, Paula Kriz, Martin Musilek, Xin Wang, Jeni Vuong, Leonard W. Mayer, Michael W. Pride, Kathrin U. Jansen & Annaliesa S. Anderson. (2018) Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine. mBio 9:2.
Crossref
Crossref
Li Hao, Matthew T. G. Holden, Xin Wang, Lubomira Andrew, Sabine Wellnitz, Fang Hu, Melissa Whaley, Scott Sammons, Kristen Knipe, Mike Frace, Lucy A. McNamara, Paul Liberator & Annaliesa S. Anderson. (2018) Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA. Microbial Genomics 4:4.
Crossref
Crossref
Federico Martinón-Torres, Alfonso Carmona Martinez, Róbert Simkó, Pilar Infante Marquez, Josep-Lluis Arimany, Francisco Gimenez-Sanchez, José Antonio Couceiro Gianzo, Éva Kovács, Pablo Rojo, Huajun Wang, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Antibody persistence and booster responses 24–36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial. Journal of Infection 76:3, pages 258-269.
Crossref
Crossref
Matt Shirley & Muhamed-Kheir Taha. (2018) MenB-FHbp Meningococcal Group B Vaccine (Trumenba®): A Review in Active Immunization in Individuals Aged ≥ 10 Years. Drugs 78:2, pages 257-268.
Crossref
Crossref
Charlene M.C. Rodrigues & Martin C.J. Maiden. (2018) A world without bacterial meningitis: how genomic epidemiology can inform vaccination strategy. F1000Research 7, pages 401.
Crossref
Crossref